Correlation Between Prime Medicine, and Axonic Strategic
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Axonic Strategic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Axonic Strategic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Axonic Strategic Income, you can compare the effects of market volatilities on Prime Medicine, and Axonic Strategic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Axonic Strategic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Axonic Strategic.
Diversification Opportunities for Prime Medicine, and Axonic Strategic
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Prime and Axonic is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Axonic Strategic Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axonic Strategic Income and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Axonic Strategic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axonic Strategic Income has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Axonic Strategic go up and down completely randomly.
Pair Corralation between Prime Medicine, and Axonic Strategic
Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the Axonic Strategic. In addition to that, Prime Medicine, is 36.96 times more volatile than Axonic Strategic Income. It trades about -0.05 of its total potential returns per unit of risk. Axonic Strategic Income is currently generating about -0.06 per unit of volatility. If you would invest 889.00 in Axonic Strategic Income on August 30, 2024 and sell it today you would lose (3.00) from holding Axonic Strategic Income or give up 0.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.73% |
| Values | Daily Returns |
Prime Medicine, Common vs. Axonic Strategic Income
Performance |
| Timeline |
| Prime Medicine, Common |
| Axonic Strategic Income |
Prime Medicine, and Axonic Strategic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine, and Axonic Strategic
The main advantage of trading using opposite Prime Medicine, and Axonic Strategic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Axonic Strategic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axonic Strategic will offset losses from the drop in Axonic Strategic's long position.| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
| Axonic Strategic vs. Axonic Strategic Income | Axonic Strategic vs. FT Vest Equity | Axonic Strategic vs. Zillow Group Class | Axonic Strategic vs. Northern Lights |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |